Compound Report Overview
Compound Name:
LORATADINE
Compound Identifier:
700382
Mol Structure 2D:
700382
Molecular Weight:
383
Formula:
C22 H23 Cl N2 O2
Development Status:
US FDA Approved
SMILES:
CCOC(=O)N1CCC(=C2c3ccc(Cl)cc3CCc4cccnc24)CC1
Compound Activites
| Compound | Assay | Assay Name | View |
|---|---|---|---|
| LORATADINE | 626 | Histamine H1, Central | View |
| LORATADINE | 641 | CYP450-2C19 Inhibition | View |
| LORATADINE | 643 | CYP450-2D6 Inhibition | View |
| LORATADINE | 167 | Muscarinic M1 | View |
| LORATADINE | 105 | Cannabinoid CB1 | View |
| LORATADINE | 92 | Adrenergic, Norepinephrine Transporter | View |
| LORATADINE | 90 | Adrenergic beta3 | View |
| LORATADINE | 121 | Dopamine Transporter | View |
| LORATADINE | 170 | Muscarinic M4 | View |
| LORATADINE | 175 | Tachykinin NK2 | View |
| LORATADINE | 169 | Muscarinic M3 | View |
| LORATADINE | 84 | Adrenergic alpha2A | View |
| LORATADINE | 171 | Muscarinic M5 | View |
| LORATADINE | 216 | Sodium Channel, Site 2 | View |
| LORATADINE | 205 | Serotonin 5-HT2B | View |
| LORATADINE | 168 | Muscarinic M2 | View |
| LORATADINE | 183 | Opiate mu | View |
| LORATADINE | 204 | Serotonin 5-HT2A | View |
| LORATADINE | 148 | Histamine H2 | View |
| LORATADINE | 89 | Adrenergic beta2 | View |
| LORATADINE | 102 | Calcium Channel Type L, Dihydropyridine | View |
| LORATADINE | 625 | GABAA, Chloride Channel, TBOB | View |
| LORATADINE | 103 | Calcium Channel Type L, Phenylalkylamine | View |
| LORATADINE | 181 | Opiate delta | View |
| LORATADINE | 206 | Serotonin 5-HT2C | View |
| LORATADINE | 116 | Dopamine D3 | View |
| LORATADINE | 182 | Opiate kappa | View |